Easywell Biomedicals, Inc. (1799.TWO) Key Statistics
$27.25TWO: 1799.TWOMarket Cap $3.62B
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Easywell Biomedicals, Inc. (1799.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
0.00
P/B ratioShare price divided by book value per share.
5.10
P/S ratioMarket value divided by annual revenue.
4.52
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
46.87%
Operating marginRevenue left after operating costs.
0.40%
Net marginRevenue left after every cost, including tax and interest.
-1.96%
Return on equityProfit as a percentage of shareholders’ equity.
-2.10%
Return on assetsProfit as a percentage of total assets.
-0.14%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.68
Quick ratioThe same, excluding inventory.
1.95
Debt to equityTotal borrowings against shareholders’ equity.
0.53
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-0.13
Book value per shareShareholders’ equity divided by shares outstanding.
$5.69
Shares outstandingShares currently issued.
124,690,000
Market capitalisationShare price times shares outstanding.
$3.62B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
3,118
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
Easywell Biomedicals, Inc. (1799.TWO) statistics — frequently asked questions
What is Easywell Biomedicals, Inc.'s return on equity?
Easywell Biomedicals, Inc. (1799.TWO) reports a return on equity of -2.10%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Easywell Biomedicals, Inc. carry?
Easywell Biomedicals, Inc. (1799.TWO) has a debt-to-equity ratio of 0.53, which compares total borrowings with shareholders' equity.
What is Easywell Biomedicals, Inc.'s profit margin?
Easywell Biomedicals, Inc. (1799.TWO) keeps -1.96% of revenue as net profit after every cost, including tax and interest.